ACI brings clinically proven, low-dose collagen to UK market with Morikol® deal

Morikol^® offers formulators and manufacturers a rare combination of clinical efficacy at ultra-low doses, clean-label appeal, and wide-ranging formulation potential. This makes it a standout collagen solution for new product development across the food, beverage, and nutraceutical industries, in response to growing consumer demand for science-driven beauty and joint health solutions.

Its high concentration of tripeptides, particularly Gly-Pro-Hyp, allows it to trigger meaningful skin and joint health benefits at exceptionally low doses - ideal for modern formulations.

“In the past, conventional collagen could require upwards servings from 5-10g in a formulation. However, Morikol^® delivers visible and measurable health benefits at just 1 to 2 grams per day,” explains Kasten Smet, managing director of ACI Group. “We view Morikol® as more than just a collagen powder. It’s a precision-engineered bioactive with real clinical weight behind it.”

In one 12-week placebo-controlled clinical trial, participants taking 1g/day of Morikol® showed a 10.5× greater wrinkle reduction than placebo, significant increases in skin hydration and elasticity, and noticeable improvements around the eye and cheek areas within 6 weeks.

Another 10-week study focusing on mild joint discomfort found that a 2g/day dose improved flexibility, reduced stiffness, and improved joint mobility, without the need for high-volume servings or stacked ingredients.

“Morikol^®'s low molecular weight (~300 Da) allows for rapid absorption and high bioavailability, making it uniquely effective at stimulating collagen synthesis, boosting hyaluronic acid, and enhancing ceramide production,” added Karsten.

“For manufacturers, this means smaller serving sizes for consumer convenience, reduced ingredient costs, and simplified stock keeping. It also enables seamless integration into capsules, powders, RTDs, gummies, bars, and even chocolates, as seen in DolCas’ premium collagen-infused chocolate concept. As the global collagen market soars toward $8bn by 2030, science-backed, low-dosage innovations like Morikol® represent an unmissable opportunity for forward-thinking brands.”

As a marine-sourced ingredient, Morikol® is non-GMO, free from heavy metals, and certified halal and kosher. It also meets Prop 65 compliance standards and supports clean-label product development. Whether looking to formulate a premium beauty-from-within capsule, a functional drink, or an indulgent wellness snack, Morikol® offers brands and manufacturers the technical foundation and credibility to bring it to life.

To request samples, clinical data, or formulation support, contact ACI Group today or visit www.acigroup.biz.